<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>315065</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>7667640</PubmedId>
            <Abstract>H-Y is a transplantation antigen that can lead to rejection of male organ and bone marrow grafts by female recipients, even if the donor and recipient match at the major histocompatibility locus of humans, the HLA (human leukocyte antigen) locus. However, the origin and function of H-Y antigens has eluded researchers for 40 years. One human H-Y antigen presented by HLA-B7 was identified as an 11-residue peptide derived from SMCY, an evolutionarily conserved protein encoded on the Y chromosome. The protein from the homologous gene on the X chromosome, SMCX, differs by two amino acid residues in the same region. The identification of H-Y may aid in transplantation prognosis, prenatal diagnosis, and fertilization strategies.</Abstract>
            <ArticleYear>1995</ArticleYear>
            <ArticlePages>1588-90</ArticlePages>
            <ArticleTitle>Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>W</ForeName>
                </Author>
                <Author>
                    <LastName>Meadows</LastName>
                    <ForeName>L R</ForeName>
                </Author>
                <Author>
                    <LastName>den Haan</LastName>
                    <ForeName>J M</ForeName>
                </Author>
                <Author>
                    <LastName>Sherman</LastName>
                    <ForeName>N E</ForeName>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Y</ForeName>
                </Author>
                <Author>
                    <LastName>Blokland</LastName>
                    <ForeName>E</ForeName>
                </Author>
                <Author>
                    <LastName>Shabanowitz</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>Agulnik</LastName>
                    <ForeName>A I</ForeName>
                </Author>
                <Author>
                    <LastName>Hendrickson</LastName>
                    <ForeName>R C</ForeName>
                </Author>
                <Author>
                    <LastName>Bishop</LastName>
                    <ForeName>C E</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Microbiology, University of Virginia, Charlottesville 22908, USA.</Affiliations>
            <ArticleChemicalList>H-Y Antigen;HLA-B7 Antigen;Minor Histocompatibility Antigens;Proteins;Histone Demethylases;KDM5C protein, human;KDM5D protein, human;Oxidoreductases, N-Demethylating;Histone-Lysine N-Methyltransferase</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; B-Lymphocytes; Cell Line; Chromatography, High Pressure Liquid; H-Y Antigen(chemistry; genetics; immunology); HLA-B7 Antigen(immunology); Histone Demethylases; Histone-Lysine N-Methyltransferase; Humans; Male; Mass Spectrometry(methods); Minor Histocompatibility Antigens; Molecular Sequence Data; Molecular Weight; Oxidoreductases, N-Demethylating; Proteins(chemistry; genetics; immunology); T-Lymphocytes, Cytotoxic(immunology); X Chromosome; Y Chromosome</ArticleMeshHeadingsList>
            <Comments>Data originally imported from the Database of Functional Molecular Immunology, FIMM (http://sdmc.lit.org.sg:8080/fimm/) and from the HLA Ligand Database (http://hlaligand.ouhsc.edu/)</Comments>
            <Journal>
                <Volume>269</Volume>
                <Issue>5230</Issue>
                <Title>Science (New York, N.Y.)</Title>
                <Issn>1095-9203</Issn>
                <MedlineTa>Science</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>SMCY peptide</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SPSVDKARAEL</LinearSequence>
                        <StartingPosition>950</StartingPosition>
                        <EndingPosition>960</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAC50806.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>137455</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>1796729</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Transplant/transfusion</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Derivative of Source Organism</EpitopeRelation>
                                    <Object>
                                        <DerivativeOfOrganism>
                                            <SubType>Anatomical Entity</SubType>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </DerivativeOfOrganism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Lymphocyte</ResponderCellType>
                                <StimulatorCellType>Lymphocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAC50806.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The patient was suffering from aplastic anemia and had received multiple transfusions.Lymphocytes were cultured for 6 d with lymphocytes from HLA-A, -B, and -C identical, but HLA-D different male individuals. The patient formed cytotoxic cells which specifically recognized HLA-A2 male target cells and HLA-B7 male target cells. Generation of the T Cell line was previously described in Goulmy et al. J Exp Med. 1979 Feb 1;149(2):545-50 [PMID: 310866].</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>T2 cells-Lymphoblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>300</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SPSVDKARAEL</LinearSequence>
                                        <StartingPosition>950</StartingPosition>
                                        <EndingPosition>960</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAC50806.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcLigandElution>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <MhcLigandElutionId>1796946</MhcLigandElutionId>
                        <HostOrganism>
                            <OrganismId>9606</OrganismId>
                        </HostOrganism>
                        <InVivoProcess>
                            <InVivoProcessType>No immunization</InVivoProcessType>
                        </InVivoProcess>
                        <AntigenProcessingComments>HLA-B7-molecules were immunoaffinity , purified from H-Y+ JY cells.</AntigenProcessingComments>
                        <MhcLigand>
                            <MhcLigandObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SPSVDKARAEL</LinearSequence>
                                        <StartingPosition>950</StartingPosition>
                                        <EndingPosition>960</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAC50806.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </MhcLigandObject>
                        </MhcLigand>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>JY cells-B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>300</MhcAlleleId>
                            <MhcEvidenceCode>Antibody purification</MhcEvidenceCode>
                        </MhcAllele>
                        <AssayInformation>
                            <AssayTypeId>93</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The sequence of the eluted epitope was deduced based on a CAD mass spectrum of the peptide after conversion of the Arg residue to ornithine.</AssayComments>
                        </AssayInformation>
                    </MhcLigandElution>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1796742</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>34.0</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The concentration of the epitope that inhibited the binding of an iodinated standard peptide to purified HLA-B7 was measured.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>300</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>SMCX peptide</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SPAVDKAQAEL</LinearSequence>
                        <StartingPosition>896</StartingPosition>
                        <EndingPosition>906</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>NP_001140174.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 3</LocationOfData>
                <EpitopeId>137454</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>1796740</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Transplant/transfusion</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Derivative of Source Organism</EpitopeRelation>
                                    <Object>
                                        <DerivativeOfOrganism>
                                            <SubType>Anatomical Entity</SubType>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </DerivativeOfOrganism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Lymphocyte</ResponderCellType>
                                <StimulatorCellType>Lymphocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Structurally Related</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAC50806.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The patient was suffering from aplastic anemia and had received multiple transfusions.Lymphocytes were cultured for 6 d with lymphocytes from HLA-A, -B, and -C identical, but HLA-D different male individuals. The patient formed cytotoxic cells which specifically recognized HLA-A2 male target cells and HLA-B7 male target cells. Generation of the T Cell line was previously described in Goulmy et al. J Exp Med. 1979 Feb 1;149(2):545-50 [PMID: 310866].</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>T2 cells-Lymphoblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>300</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SPAVDKAQAEL</LinearSequence>
                                        <StartingPosition>896</StartingPosition>
                                        <EndingPosition>906</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>NP_001140174.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 3</LocationOfData>
                        <MhcBindingId>1796745</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>140.0</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The concentration of the epitope that inhibited the binding of an iodinated standard peptide to purified HLA-B7 was measured.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>300</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

